Virginia Retirement Systems Et Al Homology Medicines, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	SELL	$1.55 - $3.01 $30,690 - $59,597	-19,800 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$2.6 - $4.17 $15,080 - $24,186	-5,800 Reduced 22.66%	19,800 $60,000
Q4 2021 Feb 03, 2022	BUY	$3.64 - $7.78 $33,124 - $70,798	9,100 Added 55.15%	25,600 $93,000
Q3 2021 Oct 21, 2021	BUY	$6.01 - $8.71 $24,040 - $34,840	4,000 Added 32.0%	16,500 $130,000
Q2 2021 Aug 13, 2021	BUY	$6.02 - $9.64 $75,250 - $120,500	12,500 New	12,500 $91,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.